What is the total value of India's pharmaceutical export to France?

India exported pharmaceuticals worth $970.4M to France across 31,906 verified shipments.

Which companies in France import pharmaceuticals from India?

1. PLANET PHARMA — $184.1M. 2. VIATRIS SANTE — $108.0M. 3. CSP — $43.7M. 572 buyers total.

What pharmaceutical products does India export most to France?

1. Ibuprofen Tablets 400 MG ($38.3M, 3.9%); 2. Mianserin Hydrochloride Tablets 60 MG ($33.5M, 3.5%); 3. Mianserin Hydrochloride Tablets 30 MG ($32.9M, 3.4%); 4. Intercef 200 MG Tablets 1x10's Pack ($31.2M, 3.2%); 5. Cyamemazine Viatris 100 MG Tablet (cyame ($21.4M, 2.2%)

Which ports handle pharmaceutical shipments from India to France?

Export: CHENNAI AIR, NHAVA SHEVA SEA (INNSA1), NHAVA SHEVA SEA, DELHI AIR, SAHAR AIR. Import: Le Havre, LE HAVRE, Fos sur Mer, LYON, PARIS - CHARLES DE G.

Why does France import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $970.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply France?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to France pharmaceutical trade?

$30.4K per consignment across 31,906 shipments.

How many Indian pharmaceutical companies export to France?

386 Indian companies. Largest: MYLAN LABORATORIES LIMITED with $229.9M.

How can I find verified Indian pharmaceutical suppliers for France?

TransData Nexus covers 386 active exporters with shipment history and trade values at transdatanexus.com.

India to France Pharmaceutical Export (2026) — $970.4M, 386 Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to France?

1. MYLAN LABORATORIES LIMITED — $229.9M. 2. MICRO LABS LIMITED — $92.1M. 3. INTERMED LABORATORIES PRIVATE LIMITED — $63.2M. Total: 386 suppliers.

India to France Pharmaceutical Export (2026) — $970.4M, 386 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to France

#	Formulation	Value	Share
1	Ibuprofen Tablets 400 MG	$38.3M	3.9%
2	Mianserin Hydrochloride Tablets 60 MG	$33.5M	3.5%
3	Mianserin Hydrochloride Tablets 30 MG	$32.9M	3.4%
4	Intercef 200 MG Tablets 1x10's Pack	$31.2M	3.2%
5	Cyamemazine Viatris 100 MG Tablet (cyame	$21.4M	2.2%
6	Amoxicilline Bgr 1g (amoxicillin Dispers	$19.9M	2.0%
7	Paluva Cpr 80/480mg (bt6)(antimalarial)s	$16.8M	1.7%
8	Laridox 525mg Tablets( X3's=657900 Tablets)	$13.6M	1.4%
9	Harmless Medicines, Tarka Lp 180 Mg/2 Mg9x10 Tablets (16202 Packs)	$10.2M	1.0%
10	Perindopril Arginine Viatris 5mg 90bl Tablets Packs 45418	$9.7M	1.0%
11	Perindopril Arginine Viatris 5mg 90bl Tablets Packs 44853	$9.6M	1.0%
12	Lufamet Ds Tablets 1x6's Pack	$9.1M	0.9%
13	Tablets.adione (doxylamine Succinate & Pyrid	$9.0M	0.9%
14	Intercef 100 MG Tablets 1x10's Pack	$8.6M	0.9%
15	Metformin 1000mg Tablets( 's Pack =5277960 Tablets)	$8.5M	0.9%

India exports 20+ pharmaceutical formulations to France with a combined trade value of $970.4M. Key products include Ibuprofen ($38.3M), Metformin ($8.5M), Verapamil ($6.8M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 31,906 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to France Trade Routes

1Ibuprofen$38.3M 2Metformin$8.5M 3Verapamil$6.8M

These are the top pharmaceutical products exported from India to France, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, France buyers, regulatory requirements, and logistics for that specific product corridor. Products include Ibuprofen ($38.3M), Metformin ($8.5M), Verapamil ($6.8M) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to France

1Mylan Laboratories Limited

$229.9M

2Micro Labs Limited

$92.1M

3Intermed Laboratories Private Limited

$63.2M

4Ipca Laboratories Limited

$47.0M

Port Analysis — India to France Pharmaceutical Shipments

Indian Export Ports

CHENNAI AIR0.4%

NHAVA SHEVA SEA (INNSA1)17.9%

NHAVA SHEVA SEA1.8%

DELHI AIR2.1%

SAHAR AIR6.2%

France Import Ports

Le Havre16.9%

LE HAVRE13.1%

Fos sur Mer4.4%

LYON4.8%

PARIS - CHARLES DE G8.8%

Trade Statistics

Total Value$970.4M

Shipments31,906

Indian Exporters386

France Buyers572

Avg Shipment$30K

Products20,071

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–France Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and France has experienced significant growth over the past two decades. In fiscal year 2024, India's pharmaceutical exports to France were valued at approximately $588.19 million, marking a substantial increase from previous years. This growth trajectory underscores the strengthening economic ties and the expanding role of India as a key supplier of pharmaceutical products to France.

Key milestones in this bilateral trade include the signing of the India-European Free Trade Association (EFTA) Trade and Economic Partnership Agreement on March 10, 2024. This agreement, which entered into force on October 1, 2025, aims to enhance trade relations by reducing tariffs and addressing non-tariff barriers, thereby facilitating smoother trade flows between India and France.

2India's Market Position

India holds a significant position in France's pharmaceutical import market. In fiscal year 2024, India's pharmaceutical exports to France were valued at $588.19 million, contributing to a total of $7.71 billion in exports from India to France. This positions India as a major supplier, reflecting its strategic importance in meeting France's pharmaceutical needs.

3Recent Developments

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to France identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 31,906 verified shipments from 386 Indian exporters to 572 France buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

386 Exporters

572 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to France Pharmaceutical Export

Top Pharmaceutical Formulations — India to France

Top Pharmaceutical Products — India to France Trade Routes

Top Indian Exporters to France

Port Analysis — India to France Pharmaceutical Shipments

Indian Export Ports

France Import Ports

Trade Statistics

Other Destinations

India–France Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top France Buyers from India

Product Routes

Full Dataset Access

France Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to France

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and France

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to France Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — France for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to France

1Competing Origins

2India's Competitive Edge

3Challenges & Threats

FAQ — India to France Pharmaceutical Trade